GB0320793D0 - Chemical process - Google Patents

Chemical process

Info

Publication number
GB0320793D0
GB0320793D0 GB0320793A GB0320793A GB0320793D0 GB 0320793 D0 GB0320793 D0 GB 0320793D0 GB 0320793 A GB0320793 A GB 0320793A GB 0320793 A GB0320793 A GB 0320793A GB 0320793 D0 GB0320793 D0 GB 0320793D0
Authority
GB
United Kingdom
Prior art keywords
chemical process
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0320793A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0320793A priority Critical patent/GB0320793D0/en
Publication of GB0320793D0 publication Critical patent/GB0320793D0/en
Priority to PCT/GB2004/003720 priority patent/WO2005023783A1/fr
Ceased legal-status Critical Current

Links

GB0320793A 2003-09-05 2003-09-05 Chemical process Ceased GB0320793D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0320793A GB0320793D0 (en) 2003-09-05 2003-09-05 Chemical process
PCT/GB2004/003720 WO2005023783A1 (fr) 2003-09-05 2004-09-01 Procede pour fabriquer du gefitinib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0320793A GB0320793D0 (en) 2003-09-05 2003-09-05 Chemical process

Publications (1)

Publication Number Publication Date
GB0320793D0 true GB0320793D0 (en) 2003-10-08

Family

ID=29226532

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0320793A Ceased GB0320793D0 (en) 2003-09-05 2003-09-05 Chemical process

Country Status (2)

Country Link
GB (1) GB0320793D0 (fr)
WO (1) WO2005023783A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1300118C (zh) * 2005-08-25 2007-02-14 江苏吴中苏药医药开发有限责任公司 4－(3－氯－4－氟苯基胺基)－7－甲氧基－6－(3－吗啉丙氧基)喹唑啉的制备方法
JP2010524909A (ja) 2007-04-16 2010-07-22 シプラ・リミテッド ゲフィチニブの製造方法
WO2010061400A1 (fr) * 2008-11-03 2010-06-03 Natco Pharma Limited Nouveau procédé de préparation de lapatinib et de ses sels de qualité pharmaceutique
BRPI1013854A2 (pt) * 2009-04-23 2017-05-16 Astrazeneca Ab processo para a preparação de composto, composto, e, sal de um composto
CN102120731B (zh) * 2010-01-09 2015-01-07 浙江华海药业股份有限公司 一种制备4-(3-氯-4-氟苯基胺基)-7-甲氧基-6-(3-吗啉丙氧基)喹唑啉的新方法
PT2729173T (pt) 2011-07-06 2016-09-22 Sykehuset Sorlandet Hf Terapia direccionada para egfr
CN102659716B (zh) * 2012-05-02 2014-09-10 北京国联诚辉医药技术有限公司 4-甲氧基-2-胺基-3-[3-(4-吗啉基)丙氧基]苯腈的制备方法及吉非替尼的制备工艺
KR101457453B1 (ko) * 2012-05-31 2014-11-04 주식회사 종근당 게피티닙의 제조방법 및 이의 제조에 사용되는 중간체
CN103570633B (zh) * 2012-07-27 2015-08-05 中国科学院广州生物医药与健康研究院 吉非替尼的制备方法
JP2016507493A (ja) 2012-12-21 2016-03-10 スィーケフス ソールラン ホーエフ 神経障害及び疼痛のｅｇｆｒ標的治療
CN103739558B (zh) * 2013-09-23 2016-05-04 南京优科生物医药研究有限公司 一种吉非替尼已知杂质的制备方法
CN105968103B (zh) * 2016-07-18 2018-11-27 山东罗欣药业集团恒欣药业有限公司 抗肿瘤药物阿法替尼的合成方法
CN107698523A (zh) * 2017-09-26 2018-02-16 盐城师范学院 一种酪氨酸激酶抑制剂吉非替尼的制备方法
CN109384747A (zh) * 2018-10-26 2019-02-26 苏州立新制药有限公司 吉非替尼相关物质及其制备和检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US6384223B1 (en) * 1998-07-30 2002-05-07 American Home Products Corporation Substituted quinazoline derivatives
PL360439A1 (en) * 2000-06-28 2004-09-06 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors

Also Published As

Publication number Publication date
WO2005023783A1 (fr) 2005-03-17

Similar Documents

Publication Publication Date Title
GB0324791D0 (en) Chemical process
GB0312896D0 (en) Chemical process
TWI316058B (en) Chemical process
IL165286A0 (en) Chemical process
GB0306432D0 (en) Process
GB0303659D0 (en) Process
GB0320793D0 (en) Chemical process
GB0218041D0 (en) Chemical process
GB0307259D0 (en) Process
GB0229803D0 (en) Chemical process
GB0216412D0 (en) Chemical process
GB0210370D0 (en) Chemical process
GB0222833D0 (en) Chemical process
GB0313920D0 (en) Chemical process
GB0302648D0 (en) Chemical process
GB0308672D0 (en) Process
GB0300733D0 (en) Process
GB0313909D0 (en) Chemical process
GB0313908D0 (en) Chemical process
GB0313917D0 (en) Chemical process
GB0313911D0 (en) Chemical process
GB0320795D0 (en) Chemical process
GB0313919D0 (en) Chemical process
GB0313910D0 (en) Chemical process
GB0324545D0 (en) Chemical process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)